Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael P Kim

Showing results (121-130 of 141) with videos related to

Pageof 15
Sort By:
Cancer Research|September 8, 2019
Predictive Signatures Inform the Effective Repurposing of Decitabine to Treat KRAS-Dependent Pancreatic Ductal AdenocarcinomaCarla Mottini, Hideo Tomihara, Diego Carrella, et al.
Endoscopic Ultrasound|January 21, 2021
An international study of interobserver variability of "string sign" of pancreatic cysts among experienced endosonographersSeifeldin Hakim, Emmanuel Coronel, Graciela M Nogueras González, et al.
Biorxiv : the Preprint Server for Biology|February 24, 2023
Oncogenic Kras <sup>G12D</sup> specific non-covalent inhibitor reprograms tumor microenvironment to prevent and reverse early pre-neoplastic pancreatic lesions and in combination with immunotherapy regresses advanced PDAC in a CD8 <sup>+</sup> T cells dependent mannerKrishnan K Mahadevan, Kathleen M McAndrews, Valerie S LeBleu, et al.
JAMA Surgery|July 13, 2017
Association of Clinical Factors With a Major Pathologic Response Following Preoperative Therapy for Pancreatic Ductal AdenocarcinomaJordan M Cloyd, Huamin Wang, Michael E Egger, et al.
Annals of Surgery|May 27, 2025
Repeat Versus Single Quadratus Lumborum Block to Reduce Opioids After Open Pancreatectomy (RESQU-BLOCK): A Randomized Clinical TrialBrittany C Fields, Jose M Soliz, Barbra Bryce Speer, et al.
Biorxiv : the Preprint Server for Biology|August 30, 2023
Integrated spatial transcriptomics and lipidomics of precursor lesions of pancreatic cancer identifies enrichment of long chain sulfatide biosynthesis as an early metabolic alterationMarta Sans, Yihui Chen, Fredrik I Thege, et al.
Cancer Cell|August 25, 2023
KRAS<sup>G12D</sup> inhibition reprograms the microenvironment of early and advanced pancreatic cancer to promote FAS-mediated killing by CD8<sup>+</sup> T cellsKrishnan K Mahadevan, Kathleen M McAndrews, Valerie S LeBleu, et al.
Cancer Medicine|June 26, 2024
Escalated-dose radiotherapy for unresected locally advanced pancreatic cancer: Patterns of care and survival in the United StatesChristopher Shi, Brian De, Hop S Tran Cao, et al.
The Journal of Clinical Investigation|October 25, 2022
3D imaging analysis on an organoid-based platform guides personalized treatment in pancreatic ductal adenocarcinomaYa'an Kang, Jenying Deng, Jianhua Ling, et al.
BJS Open|April 15, 2026
Development and validation of a short version of the MD Anderson Symptom Inventory for upper gastrointestinal surgery (short-MDASI-UGI-Surg) for postoperative patient-reported outcome-based careTaisuke Imamura, Koichi Tomita, Paula Marincola Smith, et al.
Pageof 15

Showing results (121-130 of 141) with videos related to

Sort By:
Pageof 15
Cancer Research|September 8, 2019
Predictive Signatures Inform the Effective Repurposing of Decitabine to Treat KRAS-Dependent Pancreatic Ductal AdenocarcinomaCarla Mottini, Hideo Tomihara, Diego Carrella, et al.
Endoscopic Ultrasound|January 21, 2021
An international study of interobserver variability of "string sign" of pancreatic cysts among experienced endosonographersSeifeldin Hakim, Emmanuel Coronel, Graciela M Nogueras González, et al.
Biorxiv : the Preprint Server for Biology|February 24, 2023
Oncogenic Kras <sup>G12D</sup> specific non-covalent inhibitor reprograms tumor microenvironment to prevent and reverse early pre-neoplastic pancreatic lesions and in combination with immunotherapy regresses advanced PDAC in a CD8 <sup>+</sup> T cells dependent mannerKrishnan K Mahadevan, Kathleen M McAndrews, Valerie S LeBleu, et al.
JAMA Surgery|July 13, 2017
Association of Clinical Factors With a Major Pathologic Response Following Preoperative Therapy for Pancreatic Ductal AdenocarcinomaJordan M Cloyd, Huamin Wang, Michael E Egger, et al.
Annals of Surgery|May 27, 2025
Repeat Versus Single Quadratus Lumborum Block to Reduce Opioids After Open Pancreatectomy (RESQU-BLOCK): A Randomized Clinical TrialBrittany C Fields, Jose M Soliz, Barbra Bryce Speer, et al.
Biorxiv : the Preprint Server for Biology|August 30, 2023
Integrated spatial transcriptomics and lipidomics of precursor lesions of pancreatic cancer identifies enrichment of long chain sulfatide biosynthesis as an early metabolic alterationMarta Sans, Yihui Chen, Fredrik I Thege, et al.
Cancer Cell|August 25, 2023
KRAS<sup>G12D</sup> inhibition reprograms the microenvironment of early and advanced pancreatic cancer to promote FAS-mediated killing by CD8<sup>+</sup> T cellsKrishnan K Mahadevan, Kathleen M McAndrews, Valerie S LeBleu, et al.
Cancer Medicine|June 26, 2024
Escalated-dose radiotherapy for unresected locally advanced pancreatic cancer: Patterns of care and survival in the United StatesChristopher Shi, Brian De, Hop S Tran Cao, et al.
The Journal of Clinical Investigation|October 25, 2022
3D imaging analysis on an organoid-based platform guides personalized treatment in pancreatic ductal adenocarcinomaYa'an Kang, Jenying Deng, Jianhua Ling, et al.
BJS Open|April 15, 2026
Development and validation of a short version of the MD Anderson Symptom Inventory for upper gastrointestinal surgery (short-MDASI-UGI-Surg) for postoperative patient-reported outcome-based careTaisuke Imamura, Koichi Tomita, Paula Marincola Smith, et al.
Pageof 15